2020
DOI: 10.1002/adhm.202000735
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Silk‐Based Biomaterials for Cardiac Tissue Engineering

Abstract: Cardiovascular diseases are one of the leading causes of death globally. Among various cardiovascular diseases, myocardial infarction is an important one. Compared with conventional treatments, cardiac tissue engineering provides an alternative to repair and regenerate the injured tissue. Among various types of materials used for tissue engineering applications, silk biomaterials have been increasingly utilized due to their biocompatibility, biological functions, and many favorable physical/chemical properties… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
50
14
3
0

Citation Types

0
47
0
0

Year Published

Range
2021
2021
2026
2026

Publication Types

Select...
54
5
3
1

Relationship

3
60

Authors

Journals

citations

Cited by 63 publications

(47 citation statements)
references

References 191 publications

0
47
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Unlike ECM-based hydrogels, which often suffer from batch variability and limited tunability, or synthetic hydrogels which are largely biologically inert, silk combines reproducibility, bioactivity, and mechanical strength [45,47]. Importantly, while previous studies have demonstrated the feasibility of incorporating vesicles into various natural and synthetic biomaterials for cardiac repair, these approaches remain limited by reliance on native EVs with limited scalability and invasiveness of intra-myocardial injection delivery [93].…”
Section: Discussion
mentioning
confidence: 99%
“…To address the challenge of systemic NV delivery, we incorporated NVs into a silk fibroin hydrogel system to control their spatiotemporal delivery directly to heart tissue. Silk fibroin, a natural biopolymer, is gaining traction for cardiovascular applications due to its biocompatibility, tunable porosity and degradation, low-cost, mechanical strength and intrinsic bioactivity, making it well suited to provide structural support to the infarcted myocardium compared to other natural biomaterials [45, 47, 102, 103]. Previous studies have demonstrated the feasibility of combining NVs in decellularized ECM-based [104] and hybrid polyvinyl alcohol/chitosan-based systems (PBA-CP) [105], enabling controlled release of NVs from different hydrogels, while maintaining wound healing capacity in vivo .…”
Section: Discussion
mentioning
confidence: 99%
“…Previous studies have demonstrated the feasibility of combining NVs in decellularized ECM-based [104] and hybrid polyvinyl alcohol/chitosan-based systems (PBA-CP) [105], enabling controlled release of NVs from different hydrogels, while maintaining wound healing capacity in vivo . Unlike ECM-based hydrogels, which often suffer from batch variability and limited tunability, or synthetic hydrogels which are largely biologically inert, silk combines reproducibility, bioactivity, and mechanical strength [45, 47]. Importantly, while previous studies have demonstrated the feasibility of incorporating vesicles into various natural and synthetic biomaterials for cardiac repair, these approaches remain limited by reliance on native EVs with limited scalability and invasiveness of intra-myocardial injection delivery [93].…”
Section: Discussion
mentioning
confidence: 99%
See 2 more Smart Citations